YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Johnson & Johnson is selling its remaining stake in Kenvue, the maker of Tylenol and Band-Aids.
Johnson & Johnson's roughly 9.5% stake in Kenvue is being sold to Goldman Sachs and JPMorgan in a debt-for-equity exchange valued at $3.75 billion.
The banks plan to sell the roughly 189.3 million shares.
Read more from Quartz.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach